Discover
DFTX
Definium Therapeutics, Inc.
36.90
2 x 24.69
2 x 42.11
bid
ask
+
2.72
7.96%
2 @ 07:04 PM
37.40 +0.50 (1.36%)
| Ytd | 175.58% | |
| 1y | 195.20% |
34.57
day range
38.04
10.68
52 week range
48.45
| Open | 34.85 | Prev Close | 34.18 | Low | 34.57 | High | 38.04 | Mkt Cap | 4.96B |
| Vol | 2.77M | Avg Vol | 2.13M | EPS | -3.70 | P/E | N/A | Forward P/E | -19.02 |
| Beta | 2.19 | Short Ratio | 5.76 | Inst. Own | 88.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 40.56 | 200-d Avg | 27.87 | 1yr Est | 72.33 |
| Income Statement | |||
| Operating Expenses | 75.08M | ||
| Research and Development Expense | 48.67M | ||
| Selling, General and Administrative Expense | 26.41M | ||
| Operating Income | -75.08M | ||
| Interest Expense | 1.23M | ||
| Net Income | -158.99M | ||
| Net Income Common Stock | -158.99M | ||
| Net Income Common Stock (USD) | -158.99M | ||
| Consolidated Income | -158.99M | ||
| Earnings per Basic Share | -1.44 | ||
| Earnings per Basic Share (USD) | -1.44 | ||
| Earnings per Diluted Share | -1.44 | ||
| Earning Before Interest & Taxes (EBIT) | -157.75M | ||
| Earning Before Interest & Taxes (USD) | -157.75M | ||
| Weighted Average Shares | 110.68M | ||
| Weighted Average Shares Diluted | 110.68M | ||
| Balance Sheet | |||
| Cash and Equivalents | 655.27M | ||
| Cash and Equivalents (USD) | 655.27M | ||
| Investments | 428.61M | ||
| Investments Current | 428.61M | ||
| Current Assets | 1.09B | ||
| Total Assets | 1.11B | ||
| Total Debt | 36.47M | ||
| Current Liabilities | 157.20M | ||
| Debt Non-Current | 36.47M | ||
| Total Liabilities | 194.22M | ||
| Accumulated Retained Earnings (Deficit) | -818.76M | ||
| Accumulated Other Comprehensive Income | 417.00K | ||
| Shareholders Equity | 918.68M | ||
| Shareholders Equity (USD) | 918.68M | ||
| Assets Non-Current | 20.80M | ||
| Total Debt (USD) | 36.47M | ||
| Goodwill and Intangible Assets | 19.92M | ||
| Liabilities Non-Current | 37.02M | ||
| Trade and Non-Trade Payables | 6.97M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 762.27M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 392.75M | ||
| Issuance (Purchase) of Equity Shares | 805.86M | ||
| Net Cash Flow from Investing | -316.74M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -316.74M | ||
| Net Cash Flow from Operations | -52.78M | ||
| Effect of Exchange Rate Changes on Cash | -1000 | ||
| Share Based Compensation | 9.64M | ||